Home Visit
Upload
.png)
FLT-3 (AML) by PCR ITD, D835 Blood Mutation Test
50+ booked in last 3 days
No special precautions
Sample Type
Blood
Recommended for
Male, Female
Report
WIthin 15 Days
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
FLT-3 (AML) by PCR ITD, D835 - Blood Overview
Risk stratification in patients who are newly diagnosed cytogenetically normal acute myelogenous leukemia (CN-AML) is important for treatment and prognosis. FLT3 gene mutation is done for CN-AML patients. Two types of mutation detected are internal tandem repeat duplication (ITD) and a point mutation at D835
CREATED BY : Dr.Shibani R Medical Writer, Medical Affairs
FLT-3 (AML) by PCR ITD, D835 Blood Mutation Test Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the FLT-3 (AML) by PCR ITD, D835 Blood Mutation Test with a clear pricing structure.
The FLT-3 (AML) by PCR ITD, D835 Blood Mutation Test Price in Ghaziabad is ₹ 4,360 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
The test is useful for risk stratification in patients with newly diagnosed cytogenetically normal acute myelogenous leukemia (CN-AML). It is useful for detecting genetic mutations in acute myeloid leukemia.
The test detects the change or mutation in FLT-3 gene in the blood.
This test requires a blood sample. A tourniquet (elastic) band is placed tightly on the upper arm. The patient is then asked to make a fist. This helps in the build-up of blood filling the veins. The skin is disinfected before needle insertion and the blood sample is collected in vacutainer.
Positive FLT-3 mutations indicate poor prognosis and requirement of aggressive treatment. Out of these ITD mutation have poorest prognosis.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp